News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Akorn, Inc. (AKRN) And Serum Institute of India, Ltd. Announce The Signing Of An Exclusive Drug Development And Distribution Agreement For Oncology And Other Injectable Products



10/19/2005 5:11:50 PM

Akorn, Inc. (OTCBB:AKRN.OB) and Serum Institute of India, Ltd. (Serum) the world's fifth largest vaccine manufacturer, today announced an exclusive drug development and distribution agreement for oncology and other injectable drug products for the United States and Canada.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES